In line with the vision and mission of the RMS to incorporate the latest advancements in medicine, the Queen Alia Heart Diseases and Surgery Center has introduced the ARC device, designed to link patients in the ICU on a single screen. This device adheres to the latest global guidelines and standards and is approved by the U.S. Food and Drug Administration.

This groundbreaking technology, the first of its kind in Jordan and the region, was announced during a specialized training workshop held at the Queen Alia Heart Diseases and Surgery Center. The ARC device integrates artificial intelligence technologies into clinical workflows within the RMS, enabling smarter decision-making, streamlining processes, and improving patient outcomes. This sets a new standard for innovation in healthcare across the region.

The ARC device represents a new generation solution for intensive care units, offering real-time patient monitoring and seamless connectivity with medical devices—including patient monitors, ventilators, infusion pumps, dialysis machines, and more. It also integrates with electronic medical record systems and converts fragmented data into actionable insights, assisting physicians in delivering safer, faster, and more efficient care.

Brigadier General Dr. Sahil Al-Hamouri, Director General of the RMS, stated that the institution continuously seeks to adopt all advanced technologies to keep pace with the latest global developments, aiming to accelerate workflows and provide high-quality, distinguished medical services to patients.

Brigadier General Dr. Issa Hijazi, Director of Queen Alia Heart Diseases and Surgery Center, explained that the ARC device has been activated today in the intensive care unit for open-heart surgery patients. The medical staff have been trained to use the device, allowing them to easily monitor patients’ conditions on a single screen, promptly identify patient status, and perform necessary rapid interventions.